CORRECTION article
Front. Med.
Sec. Ophthalmology
Post-marketing safety of pentosan polysulfate sodium: a 21-year pharmacovigilance analysis of the FAERS database
Ben Wang 1
Long Xia 1
Er-hao Bao 2
Yong-bo Zheng 1
Yu-han Li 1
Dan Han 3
Tian-yi Shao 1
Xian-zhi Liu 1
Ping-yu Zhu 1
1. Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China
2. Sichuan Provincial People's Hospital East Sichuan Hospital & Dazhou First People's Hospital, Dazhou, China
3. Department of Ultrasound, Affiliated Hospital of North Sichuan Medical College, Nanchong, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Summary
Keywords
Adverse drug events, FAERS database, Maculopathy, pentosan polysulfate sodium, Pharmacovigilance
Received
15 February 2026
Accepted
16 February 2026
Copyright
© 2026 Wang, Xia, Bao, Zheng, Li, Han, Shao, Liu and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ping-yu Zhu
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.